quinazolines has been researched along with Age-Related Memory Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chiasseu, M; Chyung, A; Fesharaki-Zadeh, A; Luo, A; Nies, SH; Smith, LM; Strittmatter, SM; Takahashi, H; Tang, SJ | 1 |
| Ham, HJ; Han, SB; Hong, JT; Lee, HP; Lee, YS; Son, DJ; Yun, J | 1 |
| Choi, JY; Choi, WR; Han, SB; Hong, JT; Jung, JK; Kim, KC; Yeo, IJ | 1 |
| Cheng, X; Deng, G; Ding, W; Guan, H; Ju, Z; Li, S; Liu, W; Ma, C; Rong, X; Wang, C; Wang, Y; Wu, C | 1 |
| Basavarajappa, BS; Subbanna, S | 1 |
| Darras, FH; Decker, M; Khan, N; Nurulain, SM; Saad, A; Sadek, B | 1 |
| Chiang, HC; Du, S; Liang, B; Ma, W; Wang, L; Wu, W; Xie, Z; Yao, X; Zhong, Y | 1 |
7 other study(ies) available for quinazolines and Age-Related Memory Disorders
| Article | Year |
|---|---|
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
Topics: Aged, 80 and over; Animals; Benzodioxoles; Brain Concussion; Enzyme Inhibitors; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Protein Aggregates; Protein Aggregation, Pathological; Proto-Oncogene Proteins c-fyn; Quinazolines; Synapses; tau Proteins; Tauopathies | 2020 |
K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway.
Topics: Animals; Brain; C-Reactive Protein; Cell Line; Chitinase-3-Like Protein 1; Gene Knockdown Techniques; Inflammation Mediators; MAP Kinase Signaling System; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Nerve Tissue Proteins; Quinazolines | 2020 |
K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Avoidance Learning; Brain; Cell Line, Transformed; Chitinase-3-Like Protein 1; Disease Models, Animal; Drug Administration Schedule; Drug Delivery Systems; Encephalitis; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Microglia; NF-kappa B; Peptide Fragments; Quinazolines; Recognition, Psychology; Retention, Psychology | 2018 |
Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice.
Topics: Acetylcholine; Alkaloids; Amnesia; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Cholinesterase Inhibitors; Cognitive Dysfunction; Hippocampus; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Neurotransmitter Agents; Oxidative Stress; Peganum; Quinazolines; Scopolamine; Sesquiterpenes | 2019 |
Pre-administration of G9a/GLP inhibitor during synaptogenesis prevents postnatal ethanol-induced LTP deficits and neurobehavioral abnormalities in adult mice.
Topics: Animals; Animals, Newborn; Azepines; Central Nervous System Depressants; Drug Administration Schedule; Electric Stimulation; Enzyme Inhibitors; Ethanol; Gene Expression Regulation, Developmental; Histone-Lysine N-Methyltransferase; In Vitro Techniques; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neurogenesis; Quinazolines; Recognition, Psychology; Social Behavior | 2014 |
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
Topics: Animals; Avoidance Learning; Benzothiazoles; Cholinesterase Inhibitors; Disease Models, Animal; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Histamine H3 Antagonists; Indans; Male; Memory; Memory Disorders; Nootropic Agents; Phenoxypropanolamines; Piperidines; Pyrilamine; Pyrroles; Quinazolines; Random Allocation; Rats, Wistar; Receptors, Histamine H3 | 2016 |
Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss.
Topics: Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Chlorocebus aethiops; COS Cells; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Maze Learning; Memantine; Memory; Memory Disorders; Mice; Mice, Transgenic; Molecular Structure; Peptide Fragments; Protein Kinase Inhibitors; Quinazolines | 2012 |